Please assess the completion status of the following clinical trial:

Trial Title: Effects of Dietary Conditions on Drug Response

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-45 years~* Fluent in written and spoken English and is capable of understanding and complying with the protocol~* Medically healthy~* Non-smoker~* Appropriate dietary/over-the-counter/prescription/illicit drug use history~* Body Mass Index between 18.5 and 34.9~* Appropriate use of birth control in females e.g., barrier methods, hormonal contraceptives, Intra Uterine Devices (IUDs)~Exclusion Criteria:~* Known hypersensitivity to administered drugs~* Current neurological, hepatic, renal, endocrine, cardiovascular, gastrointestinal, pulmonary or metabolic disease for which administration of the study drugs would be contraindicated~* Current psychiatric or substance use condition that would interfere with study participation~* Diastolic blood pressure \>90 mmHg or a systolic pressure of \>140 mmHg~* Use of medications that would interfere with study participation~* Unwilling or unable to comply with the protocol~* Any other serious disease or condition that might affect life expectancy or make it difficult to successfully manage the subjects according to the protocol~* Females: Pregnancy, breastfeeding, or plans to become pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Caffeine Maintenance (Type: EXPERIMENTAL): All participants will receive the same drug conditions, but the order in which the participants receive the drug conditions will be different across participants. Thus, comparisons of the drug conditions on mood and choice will be compared within-subjects (e.g., between drug and placebo). During the caffeine maintenance condition, participants will ingest 200 mg of caffeine orally in capsules three times daily.
- Placebo Maintenance (Type: PLACEBO_COMPARATOR): All participants will receive the same drug conditions, but the order in which the participants receive the drug conditions will be different across participants. Thus, comparisons of the drug conditions on mood and choice will be compared within-subjects (e.g., between drug and placebo). The placebo maintenance condition will be identical to the caffeine maintenance condition, with the exception that the thrice daily capsules will contain placebo (microcrystalline cellulose) rather than containing caffeine.

Based on this trial design, predict the completion outcome and termination type (if applicable).